Navigation Links
Innovation and Global Clinical Trial Participation are the Focus of CenterWatch's Latest Special Report on China's Drug Development Industry
Date:9/29/2009

CenterWatch set to release the latest report in its series on emerging markets of clinical research, China: A New Era of Innovation in Drug Development.

Boston, MA (PRWEB) September 29, 2099 -- China's new investments in its domestic pharma industry are beginning to drive growth and reforms that are stimulating a new drug development culture, according to CenterWatch's latest special report, China: A New Era of Innovation in Drug Development.

Scheduled for release in early October, the fifth report in CenterWatch's clinical research series reveals the initial benefits of China's efforts and the various reforms in progress, as well as a look at the further initiatives needed to make the country a major player in the drug development arena.

"CenterWatch has analyzed how China's regulatory reforms can spur innovation in the domestic drug development community, as well as benefit Big Pharma that want to include China in their global drug development programs," says Sara Gambrill, senior editor at CenterWatch and author of the report. In addition, the report discusses Big Pharma's long-range plans to invest in the research and development sector and the talent needed in the area to successfully run trials at a global level.

Other key takeaways include a list of select CROs in the region, an up-to-date pipeline of drugs currently in development, and several charts and figures that make this an important informational resource for sponsors and CROs seeking to expand their programs in the region.

For more information or to purchase China: A New Era of Innovation in Drug Development, visit the CenterWatch bookstore at http://store.centerwatch.com.

About Sara Gambrill

Sara Gambrill is senior editor at CenterWatch and writes features about international and domestic clinical research industry trends regularly for The CenterWatch Monthly and CWWeekly. She has also written several special reports on clinical research markets, including Japan, Asia-Pacific, and Central and Eastern Europe.

About CenterWatch

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. We provide proprietary data and information about clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. CenterWatch was also the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates. Today, we have one of the largest databases of clinical trials actively seeking patients on the Internet.

###

Read the full story at http://www.prweb.com/releases/2009_CenterWatch/China/prweb2955904.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
2. An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region
3. Access Innovations Provides Support Services for Agis Network
4. Patent Reform Legislation Threatens Americas Leadership in Medical Technology Innovation
5. Heart Failure Society of America 11th Annual Scientific Meeting to Focus on Heart Failure Guidelines, Innovation and New Research
6. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
7. An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area
8. An Innovation in Health Care Opens at CVS/pharmacy Stores in Pittsburgh
9. Prize for Cutting-Edge Laser Innovations
10. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
11. Kerry Extends, Improves Small Business Innovation Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Innovation and Global Clinical Trial Participation are the Focus of CenterWatch's Latest Special Report on China's Drug Development Industry
(Date:12/2/2016)... ... December 02, 2016 , ... More than ... Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. ... for area students and operating support to UNCF-member institutions, including Miles College, Oakwood ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi Hovsepian, a leading ... the 2016 “Guide to America’s Top Plastic Surgeons” for seven consecutive years. The ... education, experience, and professional associations. , One the most frequently honored surgeons ...
(Date:12/2/2016)... ... 02, 2016 , ... The PAINWeekEnd Regional Conference will be ... in Honolulu, offering local frontline clinicians the opportunity to extend their certified continuing ... for supplemental training related to pain management has surged dramatically in recent years, ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Yisrayl Hawkins, at ... into how this current generation fits into Bible Prophecy. Yisrayl says this generation, known ... pointing to this conclusion, showing how the details line up exactly with Bible Prophecy ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... On Thursday, the NASDAQ Composite ended the trading ... edged 0.36% higher, to finish at 19,191.93; and the S&P ... as six out of nine sectors ended the day in ... Services equities: Myriad Genetics Inc. (NASDAQ: MYGN ), ... Inc. (NASDAQ: INCR ), and La Quinta Holdings ...
(Date:12/2/2016)... 2016  Today, Simpson Healthcare Executives, a global leader ... selected as winners of multiple awards at the 2016 ... the PLATINUM level, Blue Zones Menu at the GOLD ... Level, and our proprietary 3ConneX Platform at the HONORABLE ... we are excited to showcase our new Platinum and ...
(Date:12/2/2016)... Columbia , December 2, 2016 bioLytical Laboratories ... gegeben, ab diesem Monat seinen  INSTI HIV-Selbsttests  in einer Version mit geringeren ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical ... ,      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ...
Breaking Medicine Technology: